Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Adolescents and human immunodeficiency virus infection: the role of the pediatrician in prevention and intervention.

BIBLIOGRAPHIC SOURCE(S)

  • American Academy of Pediatrics, Committee on Pediatric AIDS and Committee on Adolescence. Adolescents and human immunodeficiency virus infection: the role of the pediatrician in prevention and intervention. Pediatrics 2001 Jan;107(1):188-90. [9 references]

GUIDELINE STATUS

This is the current release of the guideline.

American Academy of Pediatrics (AAP) Policies are reviewed every 3 years by the authoring body. The AAP review process involves an evaluation of new literature that has emerged since the original publication date. Following this review, a recommendation is made that the policy be retired, revised, or reaffirmed without change. Until the Board of Directors approves a revision or reaffirmation, or retires a statement, the current policy remains in effect.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

  1. Information about human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) and the availability of HIV testing should be regarded as an essential component of the anticipatory guidance provided by pediatricians to all adolescent patients. This guidance should include information about HIV prevention and transmission and implications of infection.
  2. Prevention guidance should include helping adolescents understand the responsibilities of becoming sexually active. Information should be provided on abstinence from sexual activity and use of safer sexual practices to reduce the risk of unplanned pregnancy and sexually transmitted diseases, including HIV. All adolescents should be counseled about the correct and consistent use of latex condoms to reduce risk of infection.
  3. Availability of HIV testing should be discussed with all adolescents and should be encouraged with consent for those who are sexually active or substance users.
  4. Although parental involvement in adolescent health care is a desirable goal, consent of an adolescent alone should be sufficient to provide evaluation and treatment for suspected or confirmed HIV infection.
  5. A negative HIV test result can allay anxiety resulting from a high-risk event or high-risk behaviors and is a good opportunity to counsel on reducing high-risk behaviors to reduce future risk.
  6. For adolescents with a positive HIV test result, it is important to provide support, address medical and psychosocial needs, and arrange linkages to appropriate care.
  7. Pediatricians should help adolescents with HIV infection to understand the importance of informing their sexual partners of their potential exposure to HIV. Pediatricians can provide this help directly or via referral to a state or local health department's partner referral program.
  8. Pediatricians should advocate for the special needs of adolescents for information about HIV, access to HIV testing and counseling, and HIV treatment.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of evidence supporting each recommendation is not specifically stated.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • American Academy of Pediatrics, Committee on Pediatric AIDS and Committee on Adolescence. Adolescents and human immunodeficiency virus infection: the role of the pediatrician in prevention and intervention. Pediatrics 2001 Jan;107(1):188-90. [9 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2001 Jan (reaffirmed 2005 Jan)

GUIDELINE DEVELOPER(S)

American Academy of Pediatrics - Medical Specialty Society

SOURCE(S) OF FUNDING

American Academy of Pediatrics

GUIDELINE COMMITTEE

Committee on Pediatric AIDS

Committee on Adolescence

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Committee on Pediatric AIDS, 2000-2001: Mark W. Kline, MD, Chairperson; Robert J. Boyle, MD; Donna Futterman, MD; Peter L. Havens, MD; Susan King, MD; Lynne M. Mofenson, MD; Gwendolyn B. Scott, MD; Diane W. Wara, MD; Patricia N. Whitley-Williams, MD
Liaison Representative: Mary Lou Lindegren, MD (Centers for Disease Control and Prevention)
Staff: Eileen Casey, MS

Committee on Adolescence, 2000-2001: David W. Kaplan, MD, MPH, Chairperson; Ronald A. Feinstein, MD; Martin M. Fisher, MD; Jonathan D. Klein, MD, MPH; Luis F. Olmedo, MD; Ellen S. Rome, MD, MPH; W. Samuel Yancy, MD
Liaison Representatives: Paula J. Adams Hillard, MD (American College of Obstetricians and Gynecologists); Glen Pearson, MD (American Academy of Child and Adolescent Psychiatry); Diane Sacks, MD (Canadian Paediatric Society)
Section Liaison: Barbara L. Frankowski, MD, MPH (Section on School Health)
Staff: Tammy Piazza Hurley

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

American Academy of Pediatrics (AAP) Policies are reviewed every 3 years by the authoring body. The AAP review process involves an evaluation of new literature that has emerged since the original publication date. Following this review, a recommendation is made that the policy be retired, revised, or reaffirmed without change. Until the Board of Directors approves a revision or reaffirmation, or retires a statement, the current policy remains in effect.

GUIDELINE AVAILABILITY

Electronic copies: Available from the American Academy of Pediatrics (AAP) Policy Web site.

Print copies: Available from AAP, 141 Northwest Point Blvd., P.O. Box 927, Elk Grove Village, IL 60009-0927.

AVAILABILITY OF COMPANION DOCUMENTS

The following related American Academy of Pediatrics (AAP) position statements are cited by the original guideline:

  1. American Academy of Pediatrics, Committee on Adolescence. Condom availability for youth. Pediatrics 1995 Feb;95(2):281-5. (Note – this document has been updated by the position statement titled "Condom Use by Adolescents" [Pediatrics 2001 Jun;107(6):1463-9] -- this update is available from the AAP Policy Web site.)
  2. American Academy of Pediatrics, Committee on Adolescence. Contraception and adolescents. Pediatrics 1999 Nov;104(5 Pt 1):1161-6. Available from the AAP Policy Web site.
  3. American Academy of Pediatrics, Committee on Adolescence. Sexually transmitted diseases. Pediatrics 1994;94:568-72. Electronic copies are not available.
  4. American Academy of Pediatrics, Committee on Sports Medicine and Fitness. Human immunodeficiency virus and other blood-borne viral pathogens in the athletic setting. Pediatrics. 1999;104(6):1400-3. Available from the AAP Policy Web site.
  5. American Academy of Pediatrics, Committee on Pediatric AIDS. Education of children with human immunodeficiency virus infection. Pediatrics. 2000;105(6):1358-60. Available from the AAP Policy Web site.

Print copies: Available from AAP, 141 Northwest Point Blvd., P.O. Box 927, Elk Grove Village, IL 60009-0927.

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on October 17, 2001. The information was verified by the guideline developer as of December 5, 2001.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions. Please contact the Permissions Editor, American Academy of Pediatrics (AAP), 141 Northwest Point Blvd, Elk Grove Village, IL 60007.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo